hg_28018.1

Basic information about the TSS

---

TSS ID: hg_28018.1 Species: human Chr: chr2		Start: 42361198 End: 42361226 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000234301.3 BC007095 AB007618 BC005251 Distance: 0 GeneID: 9167 HGNC/MGI_ID: HGNC:2289 UniProt_ID: Q6FGA0

Gene_name: cytochrome c oxidase subunit 7A2 like Gene_symbol: COX7A2L Gene_synonyms: COX7AR COX7RP EB1 SCAF1 SCAFI SIG81 Gene_source: HGNC:2289

TATA-Box annotation

---

Distance to TSS:	5
Nearest PromoterID:	NM_004718
Entrez ID:	9167
Nearest Unigene:	Hs.339639
Nearest Refseq:	NM_004718
Nearest Ensembl:	ENSG00000115944
Gene Name:	cytochrome c oxidase subunit 7A2 like
Gene Alias:	COX7AR|COX7RP|EB1|SIG81
Gene Description:	cytochrome c oxidase subunit 7A2 like
Gene Type:	protein-coding
CpG%:	0.075
GC%:	0.626866
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@COX7A2L p2@COX7A2L
Sample		p1@COX7A2L	p2@COX7A2L
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	59.22	6.43
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	46.94	5.26
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	48.42	5.02
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	44.70	5.41
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	45.67	6.97
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	41.28	6.40
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	55.56	12.64
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	58.86	7.51
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	57.06	7.48
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	60.28	8.11
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	48.91	11.32
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	48.38	10.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	93.81	11.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	72.92	14.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	68.72	14.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	66.90	12.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	61.59	8.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	67.49	10.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	53.32	14.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	131.49	17.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	96.10	14.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	114.62	17.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	67.86	12.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	72.80	10.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	75.33	13.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	77.55	17.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	62.09	12.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	135.09	15.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	99.98	17.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	116.72	15.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	88.97	15.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	72.29	18.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	75.13	17.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	86.26	25.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	130.33	13.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	109.42	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	112.00	13.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	88.25	11.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	120.47	18.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	85.46	14.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	71.05	14.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	95.45	17.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	129.28	14.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	105.42	16.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	128.90	14.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	116.32	17.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	109.16	15.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	115.64	24.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	95.27	11.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	129.81	21.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	120.72	29.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	85.84	22.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	223.87	41.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	71.68	14.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	71.58	16.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	85.57	36.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	69.35	29.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	92.05	16.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	71.62	14.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	84.24	28.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	52.17	18.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	58.32	15.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	58.91	18.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	67.95	39.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	118.92	21.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	56.80	18.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	145.48	48.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	118.46	71.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	49.24	19.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	60.00	27.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	42.22	29.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	53.32	21.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	81.36	25.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	51.37	23.54
Adipocyte - breast, donor1	11376-118A8	35.32	19.80
Adipocyte - breast, donor2	11327-117E4	38.18	23.42
Adipocyte - omental, donor1	11473-119C6	35.50	21.50
Adipocyte - omental, donor2	11474-119C7	36.63	11.21
Adipocyte - omental, donor3	11475-119C8	36.51	19.76
Adipocyte - perirenal, donor1	11476-119C9	33.18	22.97
Adipocyte - subcutaneous, donor1	11259-116F8	57.17	23.09
Adipocyte - subcutaneous, donor2	11336-117F4	50.13	16.71
Adipocyte - subcutaneous, donor3	11408-118E4	67.43	9.91
Adipocyte differentiation, day04, donor1	13019-139D4	46.15	16.82
Adipocyte differentiation, day04, donor2	13022-139D7	31.66	16.99
Adipocyte differentiation, day04, donor3	13025-139E1	35.96	17.01
Adipocyte differentiation, day04, donor4	13028-139E4	38.80	12.93
Adipocyte differentiation, day08, donor1	13020-139D5	40.30	17.94
Adipocyte differentiation, day08, donor2	13023-139D8	43.57	18.40
Adipocyte differentiation, day08, donor3	13026-139E2	26.66	18.66
Adipocyte differentiation, day08, donor4	13029-139E5	21.70	15.02
Adipocyte differentiation, day12, donor1	13021-139D6	48.24	14.56
Adipocyte differentiation, day12, donor2	13024-139D9	33.91	17.33
Adipocyte differentiation, day12, donor3	13027-139E3	35.67	17.67
Adipocyte differentiation, day12, donor4	13030-139E6	26.18	11.57
Alveolar Epithelial Cells, donor1	11510-119G7	41.33	17.02
Alveolar Epithelial Cells, donor2	11590-120G6	40.88	11.47
Alveolar Epithelial Cells, donor3	11671-122G6	65.89	4.79
Amniotic Epithelial Cells, donor1	11533-120A3	51.99	13.85
Amniotic Epithelial Cells, donor2	11613-122A2	80.33	11.71
Amniotic Epithelial Cells, donor3	11694-123A2	75.81	15.20
Anulus Pulposus Cell, donor1	11248-116E6	68.66	11.21
Anulus Pulposus Cell, donor2	11463-119B5	45.31	10.29
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	55.71	14.83
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	64.25	14.33
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	66.35	23.54
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	56.50	9.27
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	65.76	12.65
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	46.86	12.54
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	42.24	8.12
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	53.88	15.05
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	49.89	13.66
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	48.59	12.05
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	47.89	11.61
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	47.64	10.03
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	37.40	10.71
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	35.48	5.46
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	44.48	10.86
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	54.11	12.86
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	51.39	13.41
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	43.03	12.56
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	48.77	7.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	51.42	13.93
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	48.03	16.81
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	42.48	10.62
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	44.08	13.89
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	8.39
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	53.88	9.22
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	51.98	11.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	54.51	19.38
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	46.74	11.40
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	45.11	11.12
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	42.07	11.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	43.17	6.10
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	44.37	11.58
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	48.51	7.85
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	56.16	13.45
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	46.97	11.14
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	60.59	8.32
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	53.40	17.80
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	64.69	12.99
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	34.95	14.61
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	58.69	19.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	56.73	13.55
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	44.66	10.73
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	53.85	9.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	49.50	9.49
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	41.69	6.95
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	67.60	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	45.03	10.29
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	39.11	18.65
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	61.23	13.12
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	54.25	18.85
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	48.46	15.30
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	57.46	17.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	53.05	13.42
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	38.56	12.24
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	58.32	16.73
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	53.88	14.86
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	53.40	22.89
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	47.08	16.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	42.63	11.92
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	40.34	11.63
Astrocyte - cerebellum, donor1	11500-119F6	35.37	12.53
Astrocyte - cerebellum, donor2	11580-120F5	49.81	11.98
Astrocyte - cerebellum, donor3	11661-122F5	64.81	9.02
Astrocyte - cerebral cortex, donor1	11235-116D2	47.76	11.15
Astrocyte - cerebral cortex, donor2	11316-117D2	38.66	11.97
Astrocyte - cerebral cortex, donor3	11392-118C6	56.98	9.70
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	86.01	26.03
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	81.68	29.82
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	85.35	30.16
Basophils, donor1	12241-129G9	39.23	17.52
Basophils, donor2	12242-129H1	46.90	16.60
Basophils, donor3	12243-129H2	45.57	8.82
Bronchial Epithelial Cell, donor1	11511-119G8	39.46	11.00
Bronchial Epithelial Cell, donor2	11591-120G7	29.26	3.66
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	42.68	11.30
Bronchial Epithelial Cell, donor5	11457-119A8	36.39	6.24
Bronchial Epithelial Cell, donor6	11461-119B3	86.13	8.98
Bronchial Epithelial Cell, donor7	11769-123I5	59.74	9.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	62.25	27.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	101.78	34.24
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	76.11	28.14
CD133+ stem cells - cord blood derived, pool1	12223-129E9	93.08	31.03
CD14+ Monocytes, donor1	11224-116B9	28.74	11.27
CD14+ Monocytes, donor2	11305-117B9	23.94	6.68
CD14+ Monocytes, donor3	11381-118B4	33.59	9.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	50.95	23.21
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	42.08	18.57
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	41.75	17.75
CD14+ monocytes - mock treated, donor1	11863-125A9	35.41	13.59
CD14+ monocytes - mock treated, donor2	11873-125C1	27.16	6.03
CD14+ monocytes - mock treated, donor3	11883-125D2	36.01	10.66
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	24.77	6.70
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	27.33	6.07
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	26.53	9.92
CD14+ monocytes - treated with BCG, donor1	11860-125A6	28.98	5.68
CD14+ monocytes - treated with BCG, donor2	11870-125B7	36.68	6.59
CD14+ monocytes - treated with BCG, donor3	11880-125C8	33.30	10.23
CD14+ monocytes - treated with Candida, donor1	11868-125B5	28.80	7.73
CD14+ monocytes - treated with Candida, donor2	11878-125C6	32.74	6.34
CD14+ monocytes - treated with Candida, donor3	11888-125D7	21.08	7.77
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	31.39	8.63
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	21.35	6.98
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	34.14	10.83
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	32.72	8.47
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	26.92	6.33
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	25.31	3.93
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	26.90	8.34
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	33.85	4.36
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	27.77	10.94
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	22.96	3.86
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	21.49	4.58
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	22.81	6.58
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	33.48	7.85
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	21.93	4.09
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	38.80	7.11
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	17.20	6.55
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	21.09	3.94
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	32.25	7.42
CD14+CD16+ Monocytes, donor1	11789-124B7	33.57	15.04
CD14+CD16+ Monocytes, donor2	11801-124D1	39.96	13.17
CD14+CD16+ Monocytes, donor3	11912-125G4	38.12	15.81
CD14+CD16- Monocytes, donor1	11788-124B6	48.27	17.44
CD14+CD16- Monocytes, donor2	11799-124C8	43.14	18.86
CD14+CD16- Monocytes, donor3	11910-125G2	40.36	15.61
CD14-CD16+ Monocytes, donor1	11790-124B8	65.32	22.46
CD14-CD16+ Monocytes, donor2	11800-124C9	45.45	14.27
CD14-CD16+ Monocytes, donor3	11911-125G3	46.32	14.53
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	56.90	30.48
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	59.66	21.70
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	81.81	32.10
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	82.62	38.91
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	80.95	27.34
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	68.09	26.67
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	65.89	29.81
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	84.37	38.23
CD19+ B Cells, donor1	11544-120B5	31.23	14.79
CD19+ B Cells, donor2	11624-122B4	39.17	7.25
CD19+ B Cells, donor3	11705-123B4	33.82	11.61
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	96.17	54.95
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	79.10	57.93
CD34+ Progenitors, donor1	11545-120B6	55.22	14.06
CD34+ Progenitors, donor2	11625-122B5	41.01	14.61
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	72.52	28.93
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	78.02	29.31
CD4+ T Cells, donor1	11225-116C1	47.13	16.78
CD4+ T Cells, donor2	11306-117C1	42.25	11.02
CD4+ T Cells, donor3	11382-118B5	49.71	22.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	43.90	42.11
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	49.86	38.18
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	50.02	45.71
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	63.05	39.82
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	81.47	47.06
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	42.85	59.33
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	43.21	42.49
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	50.33	41.01
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	52.88	35.30
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	41.24	42.59
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	43.32	53.46
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	38.72	47.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	29.94	40.48
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	53.60	42.39
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	43.44	48.45
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	54.39	27.19
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	51.99	39.12
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	57.38	43.04
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	38.57	38.01
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	42.02	36.61
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	40.14	30.47
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	59.16	34.89
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	53.29	35.53
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	44.45	32.69
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	77.20	62.35
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	85.86	59.08
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	128.42	73.98
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	56.22	50.12
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	64.54	54.72
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	64.68	56.98
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	67.68	45.12
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	117.72	62.32
CD8+ T Cells, donor1	11226-116C2	35.69	19.32
CD8+ T Cells, donor2	11307-117C2	25.53	7.13
CD8+ T Cells, donor3	11383-118B6	52.01	17.93
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	54.37	19.04
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	49.37	20.61
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	59.10	21.61
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	110.78	35.42
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	72.47	21.60
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	62.99	21.37
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	35.63	18.90
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	38.69	20.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	40.81	22.28
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	45.89	33.81
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	41.83	31.08
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	58.35	21.85
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	35.46	17.07
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	41.90	23.23
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	44.75	11.93
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	63.75	20.89
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	59.85	17.84
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	50.44	22.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	53.24	18.06
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	39.98	19.99
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	35.91	16.67
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	43.22	27.16
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	44.14	24.83
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	34.80	22.69
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	97.96	31.32
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	87.43	21.68
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	102.18	23.04
Cardiac Myocyte, donor1	11525-119I4	10.97	18.28
Cardiac Myocyte, donor2	11605-120I3	55.34	16.30
Cardiac Myocyte, donor3	11686-122I3	53.77	17.15
Chondrocyte - de diff, donor1	11261-116G1	41.95	15.25
Chondrocyte - de diff, donor2	11338-117F6	38.38	11.73
Chondrocyte - de diff, donor3	11410-118E6	69.97	18.66
Chondrocyte - re diff, donor2	11339-117F7	33.12	23.28
Chondrocyte - re diff, donor3	11411-118E7	65.92	12.94
Ciliary Epithelial Cells, donor1	11242-116D9	52.33	10.10
Ciliary Epithelial Cells, donor2	11323-117D9	58.57	10.05
Ciliary Epithelial Cells, donor3	11399-118D4	60.18	9.91
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	55.85	21.27
Corneal Epithelial Cells, donor1	11526-119I5	61.70	12.52
Corneal Epithelial Cells, donor2	11606-120I4	50.05	12.51
Corneal Epithelial Cells, donor3	11687-122I4	72.09	19.43
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	26.09	17.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	29.65	19.24
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	13.80
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	32.83	18.90
Dendritic Cells - plasmacytoid, donor1	11228-116C4	68.67	20.16
Dendritic Cells - plasmacytoid, donor2	11309-117C4	121.43	20.89
Dendritic Cells - plasmacytoid, donor3	11385-118B8	84.69	23.23
Endothelial Cells - Aortic, donor0	11207-116A1	46.20	16.51
Endothelial Cells - Aortic, donor1	11263-116G3	87.43	13.50
Endothelial Cells - Aortic, donor2	11340-117F8	29.69	11.31
Endothelial Cells - Aortic, donor3	11412-118E8	37.75	12.19
Endothelial Cells - Artery, donor1	11264-116G4	66.03	16.58
Endothelial Cells - Artery, donor2	11341-117F9	31.06	10.82
Endothelial Cells - Artery, donor3	11413-118E9	83.45	17.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	59.18	20.61
Endothelial Cells - Lymphatic, donor2	11317-117D3	54.77	15.82
Endothelial Cells - Lymphatic, donor3	11393-118C7	34.67	18.04
Endothelial Cells - Microvascular, donor1	11265-116G5	39.22	13.37
Endothelial Cells - Microvascular, donor2	11342-117G1	68.73	31.76
Endothelial Cells - Microvascular, donor3	11414-118F1	58.13	17.01
Endothelial Cells - Thoracic, donor1	11266-116G6	44.81	22.41
Endothelial Cells - Thoracic, donor2	11343-117G2	44.03	11.01
Endothelial Cells - Umbilical vein, donor1	11243-116E1	51.19	21.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	38.46	12.17
Endothelial Cells - Umbilical vein, donor3	11400-118D5	37.49	14.17
Endothelial Cells - Vein, donor1	11267-116G7	65.98	13.65
Endothelial Cells - Vein, donor2	11344-117G3	24.45	10.48
Endothelial Cells - Vein, donor3	11416-118F3	64.84	14.29
Eosinophils, donor1	12244-129H3	45.74	15.25
Eosinophils, donor2	12245-129H4	14.85	11.55
Eosinophils, donor3	12246-129H5	10.70	10.70
Esophageal Epithelial Cells, donor1	11507-119G4	40.31	6.84
Esophageal Epithelial Cells, donor2	11587-120G3	41.60	12.48
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	48.81
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	59.11	14.78
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	60.77	18.28
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	62.40	24.70
Fibroblast - Aortic Adventitial, donor1	11245-116E3	51.79	16.86
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	22.79	7.64
Fibroblast - Aortic Adventitial, donor2	11326-117E3	56.00	16.56
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	16.34	7.90
Fibroblast - Aortic Adventitial, donor3	11401-118D6	49.50	13.95
Fibroblast - Cardiac, donor1	11268-116G8	68.04	14.52
Fibroblast - Cardiac, donor2	11345-117G4	36.38	15.16
Fibroblast - Cardiac, donor3	11417-118F4	53.31	12.93
Fibroblast - Cardiac, donor4	11452-119A3	43.04	14.25
Fibroblast - Cardiac, donor5	11456-119A7	52.92	19.67
Fibroblast - Cardiac, donor6	11460-119B2	41.84	19.71
Fibroblast - Choroid Plexus, donor1	11492-119E7	36.45	16.21
Fibroblast - Choroid Plexus, donor2	11572-120E6	64.28	19.41
Fibroblast - Choroid Plexus, donor3	11653-122E6	73.24	14.65
Fibroblast - Conjunctival, donor1	11531-120A1	109.09	26.06
Fibroblast - Conjunctival, donor3	11692-122I9	66.32	14.76
Fibroblast - Dermal, donor1	11269-116G9	75.13	19.96
Fibroblast - Dermal, donor2	11346-117G5	58.02	19.34
Fibroblast - Dermal, donor3	11418-118F5	82.57	15.84
Fibroblast - Dermal, donor4	11450-119A1	52.34	11.19
Fibroblast - Dermal, donor5	11454-119A5	56.87	12.74
Fibroblast - Dermal, donor6	11458-119A9	55.22	18.19
Fibroblast - Gingival, donor1	11237-116D4	62.26	13.33
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	58.95	16.24
Fibroblast - Gingival, donor2	11318-117D4	59.30	15.16
Fibroblast - Gingival, donor3	11394-118C8	73.00	13.83
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	33.24	10.39
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	46.17	10.92
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	55.97	19.80
Fibroblast - Gingival, donor6 (control)	11922-125H5	48.01	15.42
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	10.59	2.82
Fibroblast - Gingival, donor7 (control)	11924-125H7	57.62	17.11
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	49.77	18.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	76.89	17.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	79.39	14.23
Fibroblast - Lung, donor1	11270-116H1	77.48	5.44
Fibroblast - Lung, donor2	11347-117G6	49.24	10.45
Fibroblast - Lung, donor3	11419-118F6	68.38	9.50
Fibroblast - Lymphatic, donor1	11506-119G3	36.65	25.82
Fibroblast - Lymphatic, donor2	11586-120G2	54.55	15.38
Fibroblast - Lymphatic, donor3	11667-122G2	36.10	8.96
Fibroblast - Mammary, donor1	11540-120B1	68.20	24.36
Fibroblast - Mammary, donor2	11620-122A9	59.91	15.98
Fibroblast - Mammary, donor3	11701-123A9	71.48	41.69
Fibroblast - Periodontal Ligament, donor1	11238-116D5	66.92	10.67
Fibroblast - Periodontal Ligament, donor2	11319-117D5	45.35	8.04
Fibroblast - Periodontal Ligament, donor3	11395-118C9	39.17	14.08
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	62.20	14.88
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	77.76	15.93
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	46.04	11.25
Fibroblast - Pulmonary Artery, donor1	11250-116E8	55.49	19.34
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	47.14	20.52
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	72.17	11.36
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	101.61	13.44
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	19.25	11.91
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	54.17	14.74
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	54.99	17.34
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	17.15	9.33
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	48.04	15.01
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	21.76	8.60
Fibroblast - skin normal, donor1	11553-120C5	45.12	15.75
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	21.25	9.02
Fibroblast - skin normal, donor2	11561-120D4	43.50	18.08
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	17.23	10.58
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	53.02	14.91
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	52.99	18.29
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	14.78	4.93
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	40.69	14.59
Fibroblast - skin walker warburg, donor1	11554-120C6	41.16	19.06
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	86.56	25.72
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	354.56	132.96
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	23.53	13.07
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	33.28	10.92
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	36.95	14.83
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	30.66	10.22
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	73.49	21.44
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	79.12	31.90
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	178.86	40.79
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	127.95	27.02
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	75.12	12.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	85.79	21.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	118.16	24.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	66.53	13.37
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	54.39	19.90
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	82.53	23.46
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	77.09	24.01
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	56.14	23.91
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	76.94	17.10
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	80.84	18.13
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	59.57	20.13
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	65.03	20.54
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	72.12	20.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	77.59	15.52
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	77.42	20.39
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	78.21	17.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	67.70	15.19
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	59.28	13.91
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	76.51	18.32
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	38.22	16.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	51.51	10.93
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	43.89	10.76
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	85.87	13.72
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	42.43	14.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.65	18.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	91.19	14.85
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	87.16	13.14
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	58.03	18.34
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	69.88	13.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	107.13	16.36
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	65.65	15.72
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	134.38	21.17
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	63.01	13.46
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	52.83	16.13
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	74.81	17.94
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	53.84	13.38
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	76.41	19.98
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	84.45	15.15
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	51.85	10.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	46.80	24.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	40.09	17.14
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	52.85	13.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	83.49	19.52
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	51.43	14.38
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	62.28	9.87
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	64.46	11.90
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	48.54	13.32
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	56.29	13.32
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	34.57	9.66
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	42.80	20.70
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	75.96	21.72
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	89.61	31.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	61.65	23.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	70.92	26.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	51.19	23.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	64.34	34.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	84.32	27.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	83.43	27.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	74.77	22.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	97.64	27.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	97.19	19.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	89.97	13.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	77.74	24.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	77.14	21.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	78.01	14.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	88.42	20.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	81.52	22.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	194.20	37.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	93.92	21.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	89.68	17.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	116.90	28.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	101.48	25.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	74.79	17.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	179.13	21.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	96.87	16.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	98.12	14.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	145.81	23.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	130.22	18.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	95.51	27.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	178.90	24.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	159.96	17.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	117.08	16.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	188.72	19.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	128.03	15.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	180.07	23.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	193.59	30.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	153.45	22.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	144.39	18.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	111.90	15.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	93.72	19.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	74.73	26.20
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	98.15	13.70
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	28.69	8.73
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	79.84	15.74
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	60.58	21.57
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	60.15	17.96
Hep-2 cells mock treated, biol_rep1	11898-125E8	40.50	10.21
Hep-2 cells mock treated, biol_rep2	11899-125E9	35.62	11.31
Hep-2 cells mock treated, biol_rep3	11900-125F1	32.08	11.83
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	40.01	12.90
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	27.08	12.89
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	32.29	12.27
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	44.96	11.71
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	39.11	11.15
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	41.01	9.29
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	43.09	21.83
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	52.37	13.42
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	52.88	21.15
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	51.14	18.34
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	60.30	11.62
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	55.07	19.06
Hepatocyte, donor1	11523-119I2	50.85	55.69
Hepatocyte, donor2	11603-120I1	28.01	43.09
Hepatocyte, donor3	11684-122I1	34.97	19.02
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	37.86	21.54
Intestinal epithelial cells (polarized), donor1	11246-116E4	52.26	19.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	51.32	9.33
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	47.76	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	66.75	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	47.07	8.31
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	60.06	7.51
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	23.74
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	56.38	10.25
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	54.85	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	51.98	6.50
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	31.68	11.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	65.35	18.15
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	66.17	7.94
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	63.19	7.76
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	73.34	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	61.10	6.93
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	55.68	9.28
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	87.81	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	62.02	5.81
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	49.91	11.27
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	60.30	6.52
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	29.81	8.82
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	54.65	13.66
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	46.16	10.16
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	61.36	11.33
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	56.23	6.35
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	47.35	4.30
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	53.36	3.81
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	49.29
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	37.62	10.84
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	43.74	9.11
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	158.04	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	53.55	5.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	36.50	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	51.55	7.41
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	42.14	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	62.86	15.72
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	38.25	8.34
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	68.61	13.28
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	77.81	9.73
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	42.72	6.10
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	89.99	18.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	52.27	13.94
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	70.41	21.34
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	52.65	6.93
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	37.04	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	34.06	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	148.24	36.30
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	99.34	18.63
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	90.93	6.34
Keratinocyte - epidermal, donor1	11272-116H3	18.60	8.73
Keratinocyte - epidermal, donor2	11349-117G8	32.80	8.20
Keratinocyte - epidermal, donor3	11421-118F8	65.69	18.46
Keratinocyte - oral, donor1	11251-116E9	67.66	15.55
Keratocytes, donor1	11527-119I6	181.54	48.48
Keratocytes, donor2	11607-120I5	90.23	17.58
Keratocytes, donor3	11688-122I5	114.61	22.13
Krukenberg tumor cell line:HSKTC	10687-109F3	28.57	4.40
Lens Epithelial Cells, donor1	11529-119I8	37.76	9.71
Lens Epithelial Cells, donor2	11609-120I7	65.62	9.23
Lens Epithelial Cells, donor3	11690-122I7	80.22	17.96
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	46.01	32.49
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	49.40	21.77
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	59.97	31.64
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	56.46	28.50
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	47.91	26.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	61.78	30.40
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	47.20	23.80
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	56.38	23.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	56.58	28.01
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	41.53	24.52
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	51.77	18.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	60.54	27.77
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	47.73	19.16
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	48.66	19.80
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	54.12	29.39
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	44.35	21.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	53.31	21.51
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	57.46	24.34
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	47.72	19.09
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	49.79	27.82
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	62.48	30.62
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	42.68	25.70
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	64.36	23.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	63.43	31.18
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	38.88	29.55
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	47.53	20.94
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	65.41	24.96
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	44.02	35.77
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	55.88	19.57
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	52.80	23.22
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	39.74	23.26
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	43.33	20.51
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	48.94	24.65
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	45.54	24.43
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	42.50	19.52
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	57.47	26.54
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	42.46	27.98
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	49.00	24.35
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	56.55	30.09
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	44.45	27.02
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	35.87	19.88
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	56.33	25.83
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	46.91	20.41
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	58.47	21.89
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	53.68	27.31
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	38.86	32.05
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	53.79	18.70
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	64.15	26.85
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	61.18	15.86
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	102.80	19.95
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	97.97	19.30
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	70.66	24.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	116.75	20.40
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	102.74	16.81
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	75.23	20.61
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	104.67	17.84
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	76.23	14.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	83.47	20.36
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	97.24	25.21
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	60.97	18.29
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	66.76	25.16
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	94.92	19.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	95.95	20.66
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	75.90	21.39
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	97.65	24.55
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	106.56	24.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	85.90	27.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	102.74	22.83
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	91.63	24.99
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	79.03	28.59
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	104.06	19.58
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	101.03	21.48
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	78.92	20.93
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	92.95	15.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	98.98	23.33
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	82.24	23.23
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	81.74	20.72
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	104.76	28.40
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	76.43	18.12
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	95.99	18.87
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	97.61	22.14
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	82.59	26.57
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	117.26	21.66
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	79.15	23.41
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	75.81	18.52
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	90.77	16.27
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	102.95	19.32
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	67.57	26.55
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	100.96	18.49
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	103.80	18.90
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	62.26	24.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	88.88	21.55
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	84.82	18.52
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	75.59	12.79
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	97.31	22.21
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	87.23	19.21
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	58.88	23.99
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	110.38	21.46
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	95.20	28.12
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	73.39	27.29
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	101.07	21.62
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	100.04	26.14
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	43.03	18.93
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	108.22	26.28
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	110.27	23.46
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	81.15	22.43
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	121.43	22.31
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	94.51	21.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	81.07	24.04
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	97.16	17.22
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	110.70	22.37
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	74.94	20.76
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	86.03	19.22
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	106.14	25.84
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	66.23	21.27
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	65.02	24.90
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	100.70	19.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	76.95	24.27
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	61.67	23.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	88.73	23.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	74.63	20.26
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	62.06	16.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	99.76	22.11
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	71.44	29.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	66.40	22.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	96.10	19.14
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	76.74	18.79
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	71.40	17.54
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	89.68	21.84
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	95.67	24.09
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	73.78	18.71
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	99.00	23.44
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	70.67	27.53
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	47.12	17.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	112.83	25.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	64.42	23.01
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	62.93	14.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	102.90	25.84
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	60.57	15.86
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	65.65	21.88
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	70.67	29.10
Macrophage - monocyte derived, donor1	11232-116C8	32.59	15.50
Macrophage - monocyte derived, donor2	11313-117C8	23.86	12.29
Macrophage - monocyte derived, donor3	11389-118C3	29.49	15.99
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	44.61	18.59
Mallassez-derived cells, donor2	11929-125I3	32.32	28.36
Mallassez-derived cells, donor3	11930-125I4	43.78	26.41
Mammary Epithelial Cell, donor1	11273-116H4	73.24	17.24
Mammary Epithelial Cell, donor2	11350-117G9	44.88	12.45
Mammary Epithelial Cell, donor3	11422-118F9	62.36	9.23
Mast cell - stimulated, donor1	11487-119E2	21.02	19.66
Mast cell, donor1	11563-120D6	46.07	20.22
Mast cell, donor2	11565-120D8	35.07	20.80
Mast cell, donor3	11566-120D9	36.92	24.54
Mast cell, donor4	11567-120E1	31.56	13.65
Mast cell, expanded and stimulated, donor5	11940-126A5	36.37	25.17
Mast cell, expanded and stimulated, donor8	11942-126A7	25.10	33.85
Mast cell, expanded, donor5	11939-126A4	33.84	21.22
Mast cell, expanded, donor8	11941-126A6	27.11	22.09
Melanocyte - dark, donor1	11502-119F8	43.18	25.87
Melanocyte - dark, donor2	11582-120F7	50.87	15.92
Melanocyte - dark, donor3	11663-122F7	34.19	20.28
Melanocyte - light, donor1	11274-116H5	23.98	11.75
Melanocyte - light, donor2	11351-117H1	15.01	3.41
Melanocyte - light, donor3	11423-118G1	32.09	13.88
Melanocyte, donor1 (MC+1)	12641-134G4	36.65	18.85
Melanocyte, donor2 (MC+2)	12739-135I3	32.81	14.79
Melanocyte, donor3 (MC+3)	12837-137B2	32.68	13.39
Meningeal Cells, donor1	11493-119E8	38.71	19.23
Meningeal Cells, donor2	11573-120E7	50.62	16.29
Meningeal Cells, donor3	11654-122E7	41.24	18.66
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	56.18	11.12
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	46.89	13.59
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	39.42	9.20
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	53.63	9.16
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	81.81	24.40
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	47.65	14.82
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	62.83	18.60
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	55.82	19.34
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	64.29	15.34
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	68.34	15.35
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	41.00	11.91
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	36.06	12.27
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	48.42	13.68
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	90.80	14.54
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	60.72	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	77.49	21.77
Mesenchymal stem cells - adipose, donor0	11217-116B2	60.96	28.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	54.41	15.64
Mesenchymal stem cells - umbilical, donor0	11214-116A8	73.29	18.87
Mesothelial Cells, donor1	11247-116E5	37.39	6.89
Mesothelial Cells, donor2	12156-128G5	34.53	6.51
Mesothelial Cells, donor3	11402-118D7	29.05	7.52
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	2.70	5.40
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	39.16	13.55
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	43.29	13.84
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	30.99	13.33
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	34.43	10.99
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	33.28	17.02
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	24.20	11.17
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	33.53	11.58
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	24.95	13.07
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	34.51	19.47
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	38.75	16.34
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	30.35	13.37
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	10.13	8.29
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	23.55	10.73
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	3.35
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	28.60	14.55
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	22.82	11.41
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.87	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	32.93	14.04
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	30.92	13.25
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	31.19	9.78
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	29.82	15.02
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	20.01	7.34
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	21.46	6.35
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	13.18	3.04
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	19.84	7.07
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	20.29	9.41
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	26.91	7.69
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	38.02	14.01
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	2.74
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	34.04	6.51
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	14.45	12.26
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	7.73	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	11.53	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	25.04	11.40
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	8.35	3.48
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	20.51	10.26
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.31	3.06
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	3.55	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	23.29	7.86
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	12.47	6.65
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.66	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	13.27	5.43
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	22.54	12.10
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	13.85	2.77
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.37	11.38
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	17.55	4.42
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	19.70	6.74
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	19.73	7.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.72	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	8.54	2.94
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	32.03	13.77
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	14.69	5.37
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	22.93	7.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	28.08	15.04
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	10.62	5.31
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	19.32	9.38
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	29.25	15.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.03	2.61
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	19.70	8.23
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	38.06	13.84
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	14.84	4.95
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	14.89	9.83
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	11.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	35.65	26.73
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	46.66	19.71
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	43.13	17.88
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	36.97	12.45
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	80.09	12.11
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	49.57	16.15
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	44.48	17.05
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	23.53	15.72
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	28.73	13.26
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	34.44	10.63
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	42.00	14.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	37.95	18.71
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	100.46	27.05
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	31.31	21.21
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	44.27	19.82
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	35.41	29.96
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	65.49	24.80
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	44.54	16.20
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	57.40	16.61
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	17.13
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	65.25	52.20
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	33.27
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	48.69	21.54
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	58.53	8.36
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	44.05	13.35
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	30.05	5.01
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	86.13	21.49
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	90.96	9.58
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	25.84	9.52
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	20.21	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	38.09	11.30
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	67.41	13.71
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	75.39	9.73
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	43.31	8.83
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	89.08	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	46.16	11.42
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	74.16	15.43
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	110.85	8.84
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	77.40	9.80
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	43.56	9.84
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	53.04	15.38
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	29.41	9.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	97.80	29.86
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	73.51	6.99
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	31.22	9.52
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	59.77	9.85
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	45.97	11.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	104.44	12.21
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	114.16	26.21
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	37.93	15.17
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	24.28	7.57
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	43.61	12.28
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	45.57	18.04
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	83.70	17.17
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	162.50	36.11
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	106.96	14.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	22.54	5.41
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	39.68	13.09
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	51.08	17.64
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	93.46	21.95
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	65.50	12.06
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	77.57	7.41
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	28.49	9.05
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	89.95	9.70
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	30.58	12.63
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	111.11	11.41
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	48.62	12.63
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	107.37	12.40
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	41.99	10.83
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	61.67	12.88
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	56.20	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	70.11	15.24
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	55.08	11.65
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	116.22	10.59
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	79.91	21.36
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	72.55	12.47
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	50.58	15.17
Myoblast, donor1	11241-116D8	54.41	17.89
Myoblast, donor2	11322-117D8	54.66	21.86
Myoblast, donor3	11398-118D3	42.21	13.12
NK T cell leukemia cell line:KHYG-1	10777-110G3	79.83	50.20
Natural Killer Cells, donor1	11230-116C6	35.06	23.06
Natural Killer Cells, donor2	11311-117C6	35.58	14.47
Natural Killer Cells, donor3	11387-118C1	28.71	13.07
Neural stem cells, donor1	11275-116H6	27.95	13.43
Neural stem cells, donor2	11352-117H2	26.96	9.63
Neurons, donor1	11494-119E9	70.55	23.90
Neurons, donor2	11574-120E8	43.81	9.69
Neurons, donor3	11655-122E8	83.86	24.66
Neutrophils, donor1	11233-116C9	25.06	12.06
Neutrophils, donor2	11314-117C9	5.80	14.49
Neutrophils, donor3	11390-118C4	22.60	7.33
Nucleus Pulposus Cell, donor1	11252-116F1	61.74	13.30
Nucleus Pulposus Cell, donor2	11409-118E5	55.03	10.42
Nucleus Pulposus Cell, donor3	11462-119B4	71.00	10.23
Olfactory epithelial cells, donor1	11933-125I7	61.53	10.74
Olfactory epithelial cells, donor2	11934-125I8	76.28	16.94
Olfactory epithelial cells, donor3	11935-125I9	71.62	12.71
Olfactory epithelial cells, donor4	11936-126A1	63.70	13.34
Oligodendrocyte - precursors, donor1	11496-119F2	46.34	16.85
Osteoblast - differentiated, donor1	11276-116H7	68.49	13.83
Osteoblast - differentiated, donor2	11353-117H3	67.44	2.29
Osteoblast - differentiated, donor3	11425-118G3	133.45	18.62
Osteoblast, donor1	11277-116H8	80.72	10.75
Osteoblast, donor2	11354-117H4	50.57	14.75
Osteoblast, donor3	11426-118G4	99.88	15.82
Pancreatic stromal cells, donor1	11249-116E7	66.80	13.81
Pericytes, donor1	11491-119E6	43.39	5.67
Pericytes, donor2	11571-120E5	75.38	10.19
Pericytes, donor3	11652-122E5	84.23	25.84
Perineurial Cells, donor1	11499-119F5	63.63	11.64
Perineurial Cells, donor2	11579-120F4	52.54	13.71
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	36.02	20.72
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	37.95	16.41
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	27.82	10.87
Placental Epithelial Cells, donor1	11278-116H9	41.14	11.72
Placental Epithelial Cells, donor2	11355-117H5	35.48	11.09
Placental Epithelial Cells, donor3	11427-118G5	75.19	11.58
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	44.62	20.89
Preadipocyte - breast, donor1	11467-119B9	27.58	17.45
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	16.05	6.92
Preadipocyte - breast, donor2	11328-117E5	61.69	23.42
Preadipocyte - omental, donor1	11468-119C1	39.32	20.99
Preadipocyte - omental, donor2	11329-117E6	37.10	12.22
Preadipocyte - omental, donor3	11403-118D8	62.89	22.06
Preadipocyte - perirenal, donor1	11469-119C2	33.47	18.70
Preadipocyte - subcutaneous, donor1	11279-116I1	42.38	14.74
Preadipocyte - subcutaneous, donor2	11356-117H6	59.68	23.37
Preadipocyte - subcutaneous, donor3	11428-118G6	93.83	20.26
Preadipocyte - visceral, donor1	11280-116I2	46.39	19.56
Preadipocyte - visceral, donor2	11357-117H7	43.72	21.63
Preadipocyte - visceral, donor3	11429-118G7	49.42	20.38
Prostate Epithelial Cells (polarized), donor1	11253-116F2	52.80	15.54
Prostate Epithelial Cells, donor2	11331-117E8	33.18	10.70
Prostate Epithelial Cells, donor3	11404-118D9	82.49	11.82
Prostate Stromal Cells, donor1	11254-116F3	61.96	15.03
Prostate Stromal Cells, donor2	11332-117E9	60.78	19.18
Prostate Stromal Cells, donor3	11405-118E1	93.12	17.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	64.60	14.60
Renal Cortical Epithelial Cells, donor2	11596-120H3	37.22	11.58
Renal Epithelial Cells, donor1	11517-119H5	38.04	5.58
Renal Epithelial Cells, donor2	11597-120H4	54.06	10.67
Renal Epithelial Cells, donor3	11678-122H4	38.32	12.60
Renal Glomerular Endothelial Cells, donor1	11514-119H2	38.13	16.34
Renal Glomerular Endothelial Cells, donor2	11594-120H1	53.37	19.41
Renal Glomerular Endothelial Cells, donor3	11675-122H1	55.28	21.09
Renal Glomerular Endothelial Cells, donor4	11783-124B1	22.63	7.32
Renal Mesangial Cells, donor1	11518-119H6	49.08	8.80
Renal Mesangial Cells, donor2	11598-120H5	48.28	14.42
Renal Mesangial Cells, donor3	11679-122H5	62.69	7.77
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	45.36	17.18
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	55.24	14.76
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	64.80	13.31
Retinal Pigment Epithelial Cells, donor0	11215-116A9	81.16	16.08
Retinal Pigment Epithelial Cells, donor1	11528-119I7	75.04	14.78
Retinal Pigment Epithelial Cells, donor2	11608-120I6	62.78	9.26
Retinal Pigment Epithelial Cells, donor3	11689-122I6	33.87	13.30
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	31.67	29.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	51.82	16.97
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	118.88	55.04
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	60.91	21.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	31.21	14.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	42.70	16.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	48.07	20.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	67.11	24.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	50.81	19.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	67.72	24.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	37.92	12.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	47.95	19.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	48.92	20.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	46.62	18.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	54.30	17.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	63.95	19.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	32.69	14.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	40.34	15.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	48.29	24.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	29.33	13.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	52.66	16.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	56.14	20.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	35.67	14.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	41.49	15.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	47.34	20.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	30.81	15.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	42.31	17.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	53.59	18.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	33.49	25.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	44.25	23.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	62.90	18.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	52.25	21.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	33.18	25.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	46.79	17.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	41.99	16.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	54.32	11.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	51.67	19.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	42.81	23.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	37.04	16.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	50.56	23.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	31.36	15.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	61.55	17.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	58.11	16.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	50.05	18.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	57.38	22.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	53.61	19.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	42.66	20.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	81.75	24.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	72.83	19.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	46.26	28.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	58.51	32.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	120.47	40.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	46.11	37.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	66.73	27.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	68.59	27.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	43.10	25.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	63.39	24.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	44.47	25.24
Schwann Cells, donor1	11498-119F4	62.44	12.60
Schwann Cells, donor2	11578-120F3	23.82	13.61
Schwann Cells, donor3	11659-122F3	51.26	12.05
Sebocyte, donor1	11220-116B5	43.82	12.60
Sebocyte, donor2	11301-117B5	82.72	19.30
Sebocyte, donor3	11378-118B1	65.96	15.25
Sertoli Cells, donor1	11255-116F4	56.32	26.51
Sertoli Cells, donor2	11333-117F1	28.24	28.24
Skeletal Muscle Cells, donor1	11281-116I3	92.55	11.00
Skeletal Muscle Cells, donor2	11358-117H8	74.45	9.40
Skeletal Muscle Cells, donor3	11430-118G8	56.01	7.52
Skeletal Muscle Cells, donor4	11451-119A2	60.80	17.28
Skeletal Muscle Cells, donor5	11455-119A6	51.58	16.95
Skeletal Muscle Cells, donor6	11459-119B1	59.87	16.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	75.60	17.26
Skeletal Muscle Satellite Cells, donor2	11321-117D7	63.50	13.13
Skeletal Muscle Satellite Cells, donor3	11397-118D2	66.47	17.66
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	73.05	18.03
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	57.18	13.03
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	83.11	12.11
Skin - palm, donor1	10286-104F7	24.17	16.12
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	25.66	12.97
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	14.72	13.90
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	22.33	12.59
Small Airway Epithelial Cells, donor1	11256-116F5	52.68	19.60
Small Airway Epithelial Cells, donor2	11334-117F2	38.54	15.05
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	18.61	10.36
Small Airway Epithelial Cells, donor3	11406-118E2	49.47	10.49
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	85.17	24.38
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	28.90	8.45
Smooth Muscle Cells - Aortic, donor0	11210-116A4	58.78	13.52
Smooth Muscle Cells - Aortic, donor1	11283-116I5	32.04	9.06
Smooth Muscle Cells - Aortic, donor2	11360-117I1	55.92	20.08
Smooth Muscle Cells - Aortic, donor3	11432-118H1	44.81	13.91
Smooth Muscle Cells - Bladder, donor1	11519-119H7	66.05	13.01
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	53.50	13.44
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	70.26	19.51
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	87.32	19.97
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	68.70	15.63
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	49.02	11.52
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	66.20	14.66
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	46.20	13.18
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	53.28	12.79
Smooth Muscle Cells - Carotid, donor1	11285-116I7	47.48	13.13
Smooth Muscle Cells - Carotid, donor2	11362-117I3	42.84	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	70.57	13.35
Smooth Muscle Cells - Colonic, donor1	11239-116D6	51.17	12.09
Smooth Muscle Cells - Colonic, donor2	11320-117D6	56.82	15.28
Smooth Muscle Cells - Colonic, donor3	11396-118D1	71.69	16.69
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	60.32	13.30
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	78.69	23.71
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	64.25	13.45
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	46.09	7.17
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	57.88	11.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	35.02	10.97
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	33.91	17.29
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	64.00	14.49
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	64.11	15.90
Smooth Muscle Cells - Prostate, donor1	11257-116F6	47.40	13.58
Smooth Muscle Cells - Prostate, donor2	11335-117F3	68.24	16.90
Smooth Muscle Cells - Prostate, donor3	11465-119B7	93.86	18.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	44.03	14.47
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	56.26	8.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	64.61	15.51
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	42.79	7.44
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	66.64	17.67
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	49.52	10.97
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	48.97	13.27
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	52.73	14.16
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	70.07	20.09
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	57.57	15.54
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	91.27	15.55
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	75.78	10.34
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	54.08	14.11
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	81.53	18.60
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	60.00	12.86
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	62.14	14.19
Smooth Muscle Cells - Uterine, donor1	11258-116F7	47.95	13.92
Smooth Muscle Cells - Uterine, donor3	11466-119B8	67.88	13.46
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	43.34	7.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	42.31	10.58
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	82.20	23.43
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	51.03	16.53
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	39.46	10.79
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	47.66	14.97
Smooth muscle cells - airway, control, donor1	11966-126D4	74.92	14.73
Smooth muscle cells - airway, control, donor2	11967-126D5	46.32	9.18
Smooth muscle cells - airway, control, donor3	11968-126D6	67.72	15.05
Smooth muscle cells - airway, control, donor4	11969-126D7	46.29	10.08
Synoviocyte, donor1	11291-117A4	43.93	13.47
Synoviocyte, donor2	11368-117I9	57.33	19.28
Synoviocyte, donor3	11440-118H9	41.33	16.31
Trabecular Meshwork Cells, donor1	11532-120A2	59.32	17.15
Trabecular Meshwork Cells, donor2	11612-122A1	77.30	7.93
Trabecular Meshwork Cells, donor3	11693-123A1	72.01	9.03
Tracheal Epithelial Cells, donor1	11292-117A5	50.39	9.68
Tracheal Epithelial Cells, donor2	11369-118A1	52.57	8.89
Tracheal Epithelial Cells, donor3	11441-118I1	41.23	6.30
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	30.76	28.42
Urethra, donor2	10319-105A4	14.39	5.40
Urothelial Cells, donor1	11520-119H8	36.13	13.28
Urothelial Cells, donor2	11600-120H7	49.67	13.22
Urothelial Cells, donor3	11681-122H7	46.99	13.06
Urothelial cells, donor0	11216-116B1	48.59	21.62
Whole blood (ribopure), donor090309, donation1	12179-129A1	13.35	34.70
Whole blood (ribopure), donor090309, donation2	12180-129A2	25.73	37.17
Whole blood (ribopure), donor090309, donation3	12181-129A3	32.17	30.12
Whole blood (ribopure), donor090325, donation1	12176-128I7	36.16	28.58
Whole blood (ribopure), donor090325, donation2	12177-128I8	20.34	26.15
Whole blood (ribopure), donor090612, donation1	12182-129A4	14.58	27.07
Whole blood (ribopure), donor090612, donation2	12183-129A5	19.27	34.88
Whole blood (ribopure), donor090612, donation3	12184-129A6	44.73	16.43
Wilms' tumor cell line:G-401	10809-111A8	66.99	18.26
Wilms' tumor cell line:HFWT	10597-108E3	52.80	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	76.53	9.50
achilles tendon, donor2	10292-104G4	24.80	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	35.69	19.12
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	65.24	20.90
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	30.27	8.19
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	40.27	19.32
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	46.66	29.51
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	69.58	38.91
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	93.64	33.21
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	62.57	18.07
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	52.27	30.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	72.61	22.13
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	57.96	30.54
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	81.91	19.50
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	36.95	20.91
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	59.03	29.77
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	38.28	14.32
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	22.31	16.27
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	33.72	28.79
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	23.33	3.68
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	56.33	16.64
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	50.95	16.07
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	49.59	19.98
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	60.81	36.97
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	36.36	12.34
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	44.60	5.57
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	55.75	30.89
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	23.12	10.03
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	78.73	13.12
adenocarcinoma cell line:IM95m	10796-110I4	59.35	23.55
adipose tissue, adult, pool1	10010-101C1	23.11	21.41
adipose, donor1	10184-103D4	158.33	57.47
adipose, donor2	10185-103D5	71.37	14.60
adipose, donor3	10186-103D6	73.52	10.07
adipose, donor4	10187-103D7	65.01	17.34
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	99.58	3.95
adrenal gland, adult, pool1	10081-102A9	174.61	25.46
adult T-cell leukemia cell line:ATN-1	10421-106C7	66.04	28.02
alveolar cell carcinoma cell line:SW 1573	10708-109H6	100.76	15.72
amniotic membrane cells, donor1	12235-129G3	51.93	7.42
amniotic membrane cells, donor2	12236-129G4	77.09	13.19
amniotic membrane cells, donor3	12237-129G5	64.81	11.19
amygdala - adult, donor10196	10167-103B5	101.98	26.09
amygdala, adult, donor10252	10151-102I7	58.80	15.21
amygdala, newborn, donor10223	10360-105E9	41.96	11.30
anaplastic carcinoma cell line:8305C	10428-106D5	166.55	23.68
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	80.75	37.29
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	103.89	11.02
aorta, adult, pool1	10052-101G7	69.63	14.12
appendix, adult	10189-103D9	46.57	19.79
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	102.49	26.83
artery, adult	10190-103E1	29.89	14.95
astrocytoma cell line:TM-31	10425-106D2	49.83	12.31
b cell line:RPMI1788	10427-106D4	67.66	20.97
basal cell carcinoma cell line:TE 354.T	10702-109G9	68.25	16.92
bile duct carcinoma cell line:HuCCT1	10432-106D9	30.66	10.72
bile duct carcinoma cell line:TFK-1	10496-107C1	57.75	8.37
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	104.58	24.05
bladder, adult, pool1	10011-101C2	36.18	10.86
blood, adult, pool1	10053-101G8	64.22	22.15
bone marrow stromal cell line:StromaNKtert	10686-109F2	29.97	10.28
bone marrow, adult	10192-103E3	23.62	24.29
brain, adult, donor1	10084-102B3	72.78	13.33
brain, adult, pool1	10012-101C3	62.25	18.93
brain, fetal, pool1	10085-102B4	98.84	13.36
breast carcinoma cell line:MCF7	10482-107A5	285.43	30.72
breast carcinoma cell line:MDA-MB-453	10419-106C5	52.55	18.22
breast, adult, donor1	10080-102A8	52.40	18.94
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	52.97	17.91
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	52.57	8.97
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	143.89	14.96
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	42.85	12.10
carcinoid cell line:NCI-H1770	10703-109H1	59.71	11.75
carcinoid cell line:NCI-H727	10735-110B6	50.97	9.08
carcinoid cell line:SK-PN-DW	10719-109I8	73.84	10.46
carcinosarcoma cell line:JHUCS-1	10642-109A3	92.36	19.70
caudate nucleus - adult, donor10196	10177-103C6	97.86	25.33
caudate nucleus, adult, donor10252	10164-103B2	80.15	17.07
caudate nucleus, adult, donor10258	10379-105H1	97.05	22.92
caudate nucleus, newborn, donor10223	10354-105E3	34.43	12.45
cerebellum - adult, donor10196	10173-103C2	101.96	8.74
cerebellum, adult, donor10252	10166-103B4	55.30	9.61
cerebellum, adult, pool1	10083-102B2	73.82	8.28
cerebellum, newborn, donor10223	10357-105E6	39.85	8.30
cerebral meninges, adult	10188-103D8	79.93	16.39
cerebrospinal fluid, donor2	10294-104G6	35.08	5.85
cervical cancer cell line:D98-AH2	10552-107I3	165.92	38.25
cervical cancer cell line:ME-180	10553-107I4	76.06	16.74
cervix, adult, pool1	10013-101C4	44.31	14.28
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	67.72	8.36
chondrosarcoma cell line:SW 1353	10700-109G7	15.68	6.53
choriocarcinoma cell line:BeWo	10423-106C9	80.66	29.70
choriocarcinoma cell line:SCH	10785-110H2	79.35	8.75
choriocarcinoma cell line:T3M-3	10618-108G6	82.06	20.87
chorionic membrane cells, donor1	12238-129G6	41.31	13.39
chorionic membrane cells, donor2	12239-129G7	47.43	14.32
chorionic membrane cells, donor3	12240-129G8	41.21	26.92
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	41.40	73.72
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	51.10	19.02
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	35.06	22.17
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	56.24	10.79
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	58.29	11.13
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	53.96	10.59
chronic myelogenous leukemia cell line:K562	10454-106G4	55.36	14.72
chronic myelogenous leukemia cell line:KU812	10409-106B4	27.89	13.55
clear cell carcinoma cell line:JHOC-5	10638-108I8	44.12	10.51
clear cell carcinoma cell line:TEN	10636-108I6	80.16	10.24
colon carcinoma cell line:CACO-2	10513-107D9	56.19	20.32
colon carcinoma cell line:COLO-320	10420-106C6	144.43	16.72
colon, adult, donor1	10082-102B1	74.97	19.04
colon, adult, pool1	10014-101C5	46.65	18.10
colon, fetal, donor1	10070-101I7	78.48	12.36
common myeloid progenitor CMP, donor1	12130-128D6	13.75	0.00
common myeloid progenitor CMP, donor2	12134-128E1	225.33	75.11
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	65.01	39.52
cord blood derived cell line:COBL-a 24h infection	10453-106G3	48.75	38.34
cord blood derived cell line:COBL-a untreated	10449-106F8	51.33	42.02
corpus callosum, adult, pool1	10042-101F6	48.76	12.71
cruciate ligament, donor2	10295-104G7	19.45	9.73
diaphragm, fetal, donor1	10069-101I6	55.38	16.85
diencephalon, adult	10193-103E4	74.64	12.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	41.33	49.60
ductal cell carcinoma cell line:KLM-1	10438-106E6	24.36	6.67
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	63.07	10.11
ductus deferens, adult	10196-103E7	34.88	29.40
duodenum, fetal, donor1, tech_rep1	10071-101I8	69.13	21.60
duodenum, fetal, donor1, tech_rep2	10071-101I8	61.06	28.69
dura mater, adult, donor1	10041-101F5	36.67	11.64
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	50.85	12.21
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	40.70	7.31
embryonic pancreas cell line:1B2C6	10604-108F1	62.89	5.55
embryonic pancreas cell line:1C3D3	10605-108F2	38.44	6.96
embryonic pancreas cell line:1C3IKEI	10606-108F3	37.98	9.26
embryonic pancreas cell line:2C6	10603-108E9	55.17	3.94
endometrial carcinoma cell line:OMC-2	10497-107C2	71.06	14.75
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	114.00	21.57
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	42.78	18.01
epidermoid carcinoma cell line:A431	10426-106D3	27.79	7.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	40.25	12.32
epididymis, adult	10197-103E8	43.75	20.30
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	45.95	4.97
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	37.36	8.65
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	83.35	14.94
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	77.36	13.29
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	83.24	14.79
esophagus, adult, pool1	10015-101C6	25.38	12.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	109.08	24.42
eye - muscle inferior rectus, donor1	10272-104E2	4.83	16.90
eye - muscle lateral, donor2	10298-104H1	16.83	6.31
eye - muscle medial, donor2	10299-104H2	31.25	5.95
eye - muscle superior, donor2	10297-104G9	27.52	4.59
eye - vitreous humor, donor1	10268-104D7	33.52	4.37
eye, fetal, donor1	10054-101G9	84.91	21.61
fibrosarcoma cell line:HT-1080	10758-110E2	58.47	23.59
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	66.48	9.02
frontal lobe, adult, pool1	10040-101F4	68.49	20.36
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	78.37	13.21
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	56.78	9.51
gall bladder, adult	10198-103E9	40.08	16.42
gamma delta positive T cells, donor1	11937-126A2	47.24	32.75
gamma delta positive T cells, donor2	11938-126A3	42.58	36.98
gastric adenocarcinoma cell line:MKN1	10614-108G2	27.67	8.66
gastric adenocarcinoma cell line:MKN45	10612-108F9	49.51	11.99
gastric cancer cell line:AZ521	10549-107H9	65.75	6.07
gastric cancer cell line:GSS	10560-108A2	75.96	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	49.35	9.82
giant cell carcinoma cell line:LU65	10487-107B1	33.73	8.38
giant cell carcinoma cell line:Lu99B	10433-106E1	59.76	7.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	32.42	9.48
glioblastoma cell line:A172, tech_rep1	10444-106F3	29.03	10.56
glioblastoma cell line:A172, tech_rep2	10444-106F3	33.14	14.18
glioblastoma cell line:T98G	10485-107A8	40.51	15.67
glioma cell line:GI-1	10413-106B8	55.06	11.42
globus pallidus - adult, donor10196	10175-103C4	110.79	10.93
globus pallidus, adult, donor10252	10161-103A8	56.14	13.18
globus pallidus, adult, donor10258	10367-105F7	42.45	9.58
globus pallidus, newborn, donor10223	10364-105F4	24.51	10.66
granulocyte macrophage progenitor, donor1	12131-128D7	9.79	9.79
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	32.79
granulocyte macrophage progenitor, donor3	12139-128E6	177.70	57.49
granulosa cell tumor cell line:KGN	10624-108H3	19.52	8.64
hIPS +CCl2, biol_rep1	14383-156B9	33.97	18.36
hIPS +CCl2, biol_rep2	14384-156C1	42.53	20.12
hIPS +CCl2, biol_rep3	14385-156C2	34.14	22.54
hIPS, biol_rep1	14380-156B6	27.31	15.81
hIPS, biol_rep2	14381-156B7	39.78	20.58
hIPS, biol_rep3	14382-156B8	57.38	16.55
hairy cell leukemia cell line:Mo	10712-109I1	57.47	25.29
heart - mitral valve, adult	10205-103F7	31.09	17.04
heart - pulmonic valve, adult	10206-103F8	36.08	13.86
heart - tricuspid valve, adult	10207-103F9	17.49	17.49
heart, adult, diseased post-infarction, donor1	10050-101G5	53.46	13.06
heart, adult, diseased, donor1	10051-101G6	66.00	20.87
heart, adult, pool1	10016-101C7	32.20	11.04
heart, fetal, pool1	10046-101G1	55.96	16.33
hepatic mesenchymal tumor cell line:LI90	10778-110G4	66.64	13.27
hepatoblastoma cell line:HuH-6	10633-108I3	34.49	4.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	98.12	42.32
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	94.06	40.17
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	94.08	41.03
hepatoma cell line:Li-7	10484-107A7	37.26	13.23
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	95.27	40.80
hippocampus - adult, donor10196	10169-103B7	86.12	14.19
hippocampus, adult, donor10252	10153-102I9	53.07	15.10
hippocampus, adult, donor10258	10374-105G5	40.83	20.91
hippocampus, newborn, donor10223	10363-105F3	18.68	8.81
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	161.13	46.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	76.38	21.01
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	71.85	24.88
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	89.09	20.86
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	117.49	23.24
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	116.54	23.92
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	76.20	16.64
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	72.38	9.91
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	66.31	11.26
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	74.35	14.68
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	94.82	11.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	82.14	10.77
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	58.84	16.27
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	84.50	16.21
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	91.64	36.66
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	83.05	23.67
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	82.42	18.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	123.44	37.48
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	88.92	14.88
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	103.22	15.46
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	92.72	15.04
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	87.20	17.80
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	87.09	18.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	75.33	21.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	79.07	21.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	68.18	22.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	93.10	29.81
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	82.74	19.36
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	71.90	16.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	84.43	18.16
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	62.57	8.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	63.10	19.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	47.20	11.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	75.16	12.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	71.18	12.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	75.28	15.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	67.86	16.91
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	70.41	31.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	84.39	23.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	74.57	19.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	296.05	87.84
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	109.54	31.11
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	71.70	8.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	65.50	9.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	55.52	9.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	36.99	8.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	65.41	9.62
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	61.96	8.62
immature langerhans cells, donor1	11904-125F5	34.38	13.08
immature langerhans cells, donor2	11905-125F6	32.48	12.67
insula, adult, pool1	10039-101F3	76.37	18.93
keratoacanthoma cell line:HKA-1	10791-110H8	37.39	15.93
kidney, adult, pool1	10017-101C8	52.47	25.03
kidney, fetal, pool1	10045-101F9	63.52	15.99
large cell lung carcinoma cell line:IA-LM	10509-107D5	28.40	5.11
large cell lung carcinoma cell line:NCI-H460	10839-111E2	83.77	14.24
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	42.39	11.93
left atrium, adult, donor1	10079-102A7	67.56	19.61
left ventricle, adult, donor1	10078-102A6	42.47	18.20
leiomyoblastoma cell line:G-402	10721-110A1	79.35	11.49
leiomyoma cell line:10964C	10569-108B2	53.89	19.04
leiomyoma cell line:15242A	10570-108B3	50.00	20.11
leiomyoma cell line:15425	10571-108B4	36.18	13.84
leiomyosarcoma cell line:Hs 5.T	10722-110A2	50.79	12.70
lens epithelial cell line:SRA 01/04	10647-109A8	21.96	8.36
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	52.30	25.38
liposarcoma cell line:KMLS-1	10782-110G8	102.32	27.96
liposarcoma cell line:SW 872	10726-110A6	27.05	6.21
liver, adult, pool1	10018-101C9	31.76	32.41
liver, fetal, pool1	10086-102B5	59.26	9.41
locus coeruleus - adult, donor10196	10182-103D2	50.31	10.21
locus coeruleus, adult, donor10252	10165-103B3	59.61	16.24
locus coeruleus, adult, donor10258	10375-105G6	74.20	17.21
locus coeruleus, newborn, donor10223	10362-105F2	33.23	18.51
lung adenocarcinoma cell line:A549	10499-107C4	83.45	15.78
lung adenocarcinoma cell line:PC-14	10408-106B3	37.92	4.14
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	36.51	6.20
lung, adult, pool1	10019-101D1	35.67	12.40
lung, fetal, donor1	10068-101I5	32.54	25.12
lung, right lower lobe, adult, donor1	10075-102A3	47.20	13.29
lymph node, adult, donor1	10077-102A5	29.82	14.67
lymphangiectasia cell line:DS-1	10727-110A7	74.30	26.08
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	55.99	35.92
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	33.13	17.84
mature adipocyte, donor1	12231-129F8	31.97	14.21
mature adipocyte, donor2	12232-129F9	27.81	18.89
mature adipocyte, donor3	12233-129G1	34.85	19.68
mature adipocyte, donor4	12234-129G2	35.01	19.21
maxillary sinus tumor cell line:HSQ-89	10414-106B9	55.51	11.67
medial frontal gyrus - adult, donor10196	10170-103B8	116.19	20.30
medial frontal gyrus, adult, donor10252	10150-102I6	62.53	15.26
medial frontal gyrus, adult, donor10258	10368-105F8	61.00	21.60
medial frontal gyrus, newborn, donor10223	10352-105E1	60.99	20.04
medial temporal gyrus - adult, donor10196	10183-103D3	89.44	22.95
medial temporal gyrus, adult, donor10252	10156-103A3	49.45	14.86
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	36.60	11.56
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	86.12	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	41.64	10.77
medulla oblongata - adult, donor10196	10174-103C3	88.91	16.87
medulla oblongata, adult, donor10252	10155-103A2	51.55	13.62
medulla oblongata, adult, pool1	10038-101F2	47.02	10.86
medulla oblongata, newborn, donor10223	10361-105F1	26.04	8.68
medulloblastoma cell line:D283 Med	10838-111E1	63.77	7.75
medulloblastoma cell line:ONS-76	10759-110E3	34.60	6.73
melanoma cell line:COLO 679	10514-107E1	49.16	23.29
melanoma cell line:G-361	10465-106H6	57.82	17.10
meningioma cell line:HKBMM	10691-109F7	40.70	11.40
merkel cell carcinoma cell line:MKL-1	10843-111E6	65.21	29.96
merkel cell carcinoma cell line:MS-1	10844-111E7	71.55	17.11
mesenchymal precursor cell - adipose, donor1	11747-123G1	72.57	30.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	72.35	18.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	28.99	26.92
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	58.58	16.30
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	65.09	21.95
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	34.70	19.43
mesenchymal precursor cell - cardiac, donor1	11752-123G6	100.58	30.04
mesenchymal precursor cell - cardiac, donor2	11753-123G7	53.48	21.74
mesenchymal precursor cell - cardiac, donor3	11754-123G8	45.49	18.97
mesenchymal precursor cell - cardiac, donor4	11755-123G9	49.83	20.53
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	45.24	16.93
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	89.26	22.07
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	55.07	20.06
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	56.20	19.90
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	73.91	22.66
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	62.19	16.53
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	45.31	12.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	30.78	7.30
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	50.35	23.91
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	66.95	23.01
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	55.41	15.06
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	89.09	26.14
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	48.93	12.88
mesenchymal stem cell line:Hu5/E18	10568-108B1	42.52	13.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	73.07	18.72
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	57.04	15.60
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	60.99	15.44
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	50.53	16.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	58.60	18.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	60.25	15.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	43.62	18.86
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	48.66	15.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	144.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	66.91	17.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	56.00	15.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	58.17	17.06
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	58.67	16.13
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	50.35	22.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	48.31	19.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	61.86	16.75
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	49.22	16.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	103.30	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	57.16	12.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	46.56	8.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	58.11	17.06
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	56.43	10.63
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	44.70	16.33
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	52.47	12.59
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	40.73	15.90
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	66.74	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	50.99	15.42
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	54.83	18.28
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	49.40	12.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	50.70	17.94
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	55.88	23.64
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	55.89	11.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	82.65	20.66
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	71.71	22.82
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	75.47	15.89
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	52.47	18.86
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	64.52	23.69
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	74.85	36.09
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	49.67	16.56
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	66.77	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	53.69	17.90
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	62.35	15.34
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	35.89	8.97
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	59.15	16.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	70.12	11.69
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	87.22	17.44
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	77.29	8.87
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	78.29	21.85
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	122.01	27.11
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	70.01	15.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	49.80	14.09
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	49.65	16.87
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	49.91	13.24
mesodermal tumor cell line:HIRS-BM	10696-109G3	27.85	6.19
mesothelioma cell line:ACC-MESO-1	10493-107B7	62.37	6.14
mesothelioma cell line:ACC-MESO-4	10494-107B8	54.44	12.97
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	25.64
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	60.83	39.25
mesothelioma cell line:Mero-25	10850-111F4	38.13	20.20
mesothelioma cell line:Mero-41	10851-111F5	38.14	11.98
mesothelioma cell line:Mero-48a	10852-111F6	34.10	14.61
mesothelioma cell line:Mero-82	10853-111F7	52.56	25.49
mesothelioma cell line:Mero-83	10854-111F8	44.09	14.64
mesothelioma cell line:Mero-84	10855-111F9	39.18	19.97
mesothelioma cell line:Mero-95	10856-111G1	35.61	16.77
mesothelioma cell line:NCI-H2052	10847-111F1	77.03	34.12
mesothelioma cell line:NCI-H226	10846-111E9	43.98	16.83
mesothelioma cell line:NCI-H2452	10848-111F2	34.85	16.57
mesothelioma cell line:NCI-H28	10845-111E8	81.17	25.19
mesothelioma cell line:No36	10857-111G2	52.19	11.09
mesothelioma cell line:ONE58	10858-111G3	27.64	25.74
migratory langerhans cells, donor1	11901-125F2	39.34	10.36
migratory langerhans cells, donor2	11902-125F3	21.00	6.72
migratory langerhans cells, donor3	11903-125F4	52.77	12.74
mixed mullerian tumor cell line:HTMMT	10689-109F5	57.13	10.77
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	58.49	15.90
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	54.13	13.36
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	47.95	30.64
myelodysplastic syndrome cell line:SKM-1	10772-110F7	111.24	26.61
myeloma cell line:PCM6	10474-106I6	142.32	64.44
myxofibrosarcoma cell line:MFH-ino	10600-108E6	28.92	3.55
myxofibrosarcoma cell line:NMFH-1	10684-109E9	51.39	16.48
nasal epithelial cells, donor1, tech_rep1	12226-129F3	78.67	9.81
nasal epithelial cells, donor1, tech_rep2	12226-129F3	87.51	10.30
nasal epithelial cells, donor2	12227-129F4	54.65	9.94
neuroblastoma cell line:CHP-134	10508-107D4	105.60	17.48
neuroblastoma cell line:NB-1	10539-107G8	69.03	20.95
neuroblastoma cell line:NBsusSR	10607-108F4	69.17	10.97
neuroblastoma cell line:NH-12	10555-107I6	194.74	28.88
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	61.44	6.88
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	68.74	8.24
neuroectodermal tumor cell line:TASK1	10774-110F9	86.74	6.64
neuroepithelioma cell line:SK-N-MC	10728-110A8	43.23	2.54
neurofibroma cell line:Hs 53.T	10729-110A9	33.54	9.85
neutrophil PMN, donor1	12133-128D9	74.37	0.00
neutrophil PMN, donor2	12137-128E4	132.81	66.40
neutrophil PMN, donor3	12141-128E8	179.94	75.77
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	40.93	37.21
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	156.10	23.21
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	59.63	16.99
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	43.09	12.61
nucleus accumbens, adult, pool1	10037-101F1	73.59	17.06
occipital cortex - adult, donor10196	10172-103C1	127.74	22.66
occipital cortex, adult, donor10252	10163-103B1	48.57	14.76
occipital cortex, newborn, donor10223	10355-105E4	33.12	13.10
occipital lobe, adult, donor1	10076-102A4	111.26	17.84
occipital lobe, fetal, donor1	10073-102A1	163.49	19.31
occipital pole, adult, pool1	10036-101E9	61.02	15.53
olfactory region, adult	10195-103E6	61.14	15.28
optic nerve, donor1	10277-104E7	22.01	12.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	77.00	18.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	42.86	10.85
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	33.86	14.05
oral squamous cell carcinoma cell line:SAS	10544-107H4	42.28	10.51
osteoclastoma cell line:Hs 706.T	10704-109H2	53.80	13.52
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	51.39	10.28
osteosarcoma cell line:HS-Os-1	10558-107I9	93.31	22.48
ovary, adult, pool1	10020-101D2	53.28	11.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	63.98	17.05
pancreas, adult, donor1	10049-101G4	70.55	22.58
pancreatic carcinoma cell line:NOR-P1	10698-109G5	70.44	16.21
papillary adenocarcinoma cell line:8505C	10437-106E5	38.50	12.78
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	38.75	11.76
paracentral gyrus, adult, pool1	10035-101E8	63.97	18.85
parietal cortex, adult, donor10258	10373-105G4	62.39	14.68
parietal lobe - adult, donor10196	10171-103B9	93.11	10.35
parietal lobe, adult, donor10252	10157-103A4	56.44	12.54
parietal lobe, adult, pool1	10034-101E7	63.09	14.54
parietal lobe, fetal, donor1	10072-101I9	131.90	17.46
parietal lobe, newborn, donor10223	10356-105E5	32.53	13.83
parotid gland, adult	10199-103F1	49.95	47.48
penis, adult	10200-103F2	47.27	19.34
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	45.93	10.78
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	102.42	34.09
pineal gland - adult, donor10196	10179-103C8	100.62	13.55
pineal gland, adult, donor10252	10160-103A7	71.07	16.58
pineal gland, adult, donor10258	10377-105G8	67.10	25.71
pituitary gland - adult, donor10196	10180-103C9	212.48	37.44
pituitary gland, adult, donor10252	10162-103A9	132.38	35.44
pituitary gland, adult, donor10258	10378-105G9	167.69	25.54
placenta, adult, pool1	10021-101D3	25.80	20.53
plasma cell leukemia cell line:ARH-77	10840-111E3	75.75	21.45
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	42.65	14.32
pons, adult, pool1	10033-101E6	66.44	13.43
postcentral gyrus, adult, pool1	10032-101E5	79.07	16.74
promyelocytes/myelocytes PMC, donor1	12132-128D8	10.46	10.46
promyelocytes/myelocytes PMC, donor2	12136-128E3	132.19	16.52
promyelocytes/myelocytes PMC, donor3	12140-128E7	211.24	58.68
prostate cancer cell line:DU145	10490-107B4	49.23	4.22
prostate cancer cell line:PC-3	10439-106E7	60.44	15.97
prostate, adult, pool1	10022-101D4	38.45	12.88
putamen, adult, donor10196	10176-103C5	145.18	25.73
putamen, adult, donor10252	10152-102I8	60.78	9.80
putamen, adult, donor10258, tech_rep1	10372-105G3	24.04	26.23
putamen, adult, donor10258, tech_rep2	10372-105G3	72.48	17.15
putamen, newborn, donor10223	10365-105F5	74.22	19.49
rectal cancer cell line:TT1TKB	10469-106I1	41.60	4.36
rectum, fetal, donor1	10067-101I4	132.14	11.13
renal cell carcinoma cell line:OS-RC-2	10411-106B6	39.01	10.18
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	52.19	25.27
retina, adult, pool1	10030-101E3	67.39	18.59
retinoblastoma cell line:Y79	10475-106I7	134.58	12.99
rhabdomyosarcoma cell line:KYM-1	10787-110H4	51.64	11.19
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	30.09	6.19
sacrococcigeal teratoma cell line:HTST	10695-109G2	28.04	5.30
salivary acinar cells, donor1	11771-123I7	75.91	14.08
salivary acinar cells, donor2	11772-123I8	66.64	19.83
salivary acinar cells, donor3	11773-123I9	25.82	9.27
salivary gland, adult, pool1	10093-102C3	33.17	40.04
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	59.78	16.02
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	76.29	13.64
seminal vesicle, adult	10201-103F3	41.80	23.28
serous adenocarcinoma cell line:JHOS-2	10639-108I9	43.24	22.35
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	66.43	23.65
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	57.20	33.12
serous cystadenocarcinoma cell line:HTOA	10693-109F9	72.40	18.54
signet ring carcinoma cell line:Kato III	10436-106E4	41.45	16.03
signet ring carcinoma cell line:NUGC-4	10483-107A6	47.35	25.16
skeletal muscle - soleus muscle, donor1	10282-104F3	17.73	9.93
skeletal muscle, adult, pool1	10023-101D5	33.94	13.79
skeletal muscle, fetal, donor1	10066-101I3	160.80	8.04
skin, adult, donor1	10074-102A2	61.07	13.57
skin, fetal, donor1	10065-101I2	67.54	14.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	69.37	16.68
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	59.57	20.17
small cell lung carcinoma cell line:DMS 144	10841-111E4	121.62	6.75
small cell lung carcinoma cell line:LK-2	10541-107H1	93.79	19.28
small cell lung carcinoma cell line:NCI-H82	10842-111E5	131.25	8.20
small cell lung carcinoma cell line:WA-hT	10562-108A4	65.38	27.24
small intestine, adult, pool1	10024-101D6	54.70	28.91
small intestine, fetal, donor1	10064-101I1	164.86	37.84
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	52.32	46.16
smooth muscle, adult, pool1	10048-101G3	42.39	8.79
somatostatinoma cell line:QGP-1	10781-110G7	92.47	20.64
spinal cord - adult, donor10196	10181-103D1	65.84	9.64
spinal cord, adult, donor10252	10159-103A6	40.22	11.43
spinal cord, adult, donor10258	10369-105F9	57.42	12.45
spinal cord, fetal, donor1	10056-101H2	68.30	14.64
spinal cord, newborn, donor10223	10359-105E8	45.00	15.15
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	37.34	12.70
spleen, adult, pool1	10025-101D7	25.99	20.37
spleen, fetal, pool1	10044-101F8	33.05	16.61
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	56.41	19.98
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	48.04	11.01
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	52.42	11.53
squamous cell carcinoma cell line:T3M-5	10616-108G4	48.08	10.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	71.25	26.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	116.07	11.01
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	38.50	8.88
stomach, fetal, donor1	10062-101H8	52.33	16.02
submaxillary gland, adult	10202-103F4	37.60	25.07
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	47.98	10.80
substantia nigra, adult, donor10258	10371-105G2	54.31	18.10
substantia nigra, newborn, donor10223	10358-105E7	19.78	9.19
synovial sarcoma cell line:HS-SY-II	10441-106E9	56.63	12.38
temporal lobe, adult, pool1	10031-101E4	68.66	17.63
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	143.17	13.53
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	80.44	14.50
tenocyte, donor1	11763-123H8	47.83	22.69
tenocyte, donor2	11765-123I1	49.21	12.21
tenocyte, donor3	11768-123I4	36.70	13.34
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	51.16	18.70
teratocarcinoma cell line:NCR-G1	10798-110I6	85.09	17.88
teratocarcinoma cell line:PA-1	10807-111A6	102.91	17.05
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	42.40	21.58
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	69.21	15.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	38.61	12.43
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	74.59	40.06
testis, adult, pool1	10026-101D8	52.93	19.43
testis, adult, pool2	10096-102C6	57.29	27.52
thalamus - adult, donor10196	10168-103B6	93.84	7.73
thalamus, adult, donor10252	10154-103A1	45.01	11.88
thalamus, adult, donor10258, tech_rep1	10370-105G1	23.09	16.94
thalamus, adult, donor10258, tech_rep2	10370-105G1	41.34	13.18
thalamus, newborn, donor10223	10366-105F6	29.34	12.66
throat, adult	10209-103G2	37.45	19.72
throat, fetal, donor1	10061-101H7	63.07	16.76
thymic carcinoma cell line:Ty-82	10803-111A2	79.29	9.74
thymus, adult, pool1	10027-101D9	46.23	16.40
thymus, fetal, pool1	10043-101F7	36.47	17.66
thyroid carcinoma cell line:KHM-5M	10776-110G2	81.50	31.25
thyroid carcinoma cell line:TCO-1	10783-110G9	39.95	5.87
thyroid, adult, pool1	10028-101E1	47.22	11.85
thyroid, fetal, donor1	10060-101H6	47.46	12.66
tongue epidermis (fungiform papillae), donor1	10288-104F9	6.16	15.40
tongue, adult	10203-103F5	40.00	25.58
tongue, fetal, donor1	10059-101H5	81.18	28.37
tonsil, adult, pool1	10047-101G2	39.17	24.14
trachea, adult, pool1	10029-101E2	26.99	21.84
trachea, fetal, donor1	10058-101H4	41.93	14.62
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	49.95	14.17
transitional-cell carcinoma cell line:5637	10418-106C4	34.75	7.90
transitional-cell carcinoma cell line:JMSU1	10492-107B6	101.53	18.49
tridermal teratoma cell line:HGRT	10694-109G1	41.86	5.71
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	98.70	19.98
umbilical cord, fetal, donor1	10057-101H3	54.25	8.35
uterus, adult, pool1	10100-102D1	30.37	16.89
uterus, fetal, donor1	10055-101H1	69.62	11.26
vagina, adult	10204-103F6	46.53	10.34
vein, adult	10191-103E2	37.48	17.32
xeroderma pigentosum b cell line:XPL 17	10563-108A5	84.92	20.29